231 related articles for article (PubMed ID: 15253056)
1. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978-2002).
Bojinova VS; Dimova PS; Belopitova LD; Mihailov AS; Gatcheva NL; Mihneva ZG; Hristova MT
Eur J Paediatr Neurol; 2004; 8(2):89-94. PubMed ID: 15253056
[TBL] [Abstract][Full Text] [Related]
2. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
[TBL] [Abstract][Full Text] [Related]
3. Changing epidemiological features of subacute sclerosing panencephalitis.
Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
Hirayasu K; Oshiro S; Nakada Y
No To Hattatsu; 2010 Nov; 42(6):427-31. PubMed ID: 21077352
[TBL] [Abstract][Full Text] [Related]
5. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Zilber N; Rannon L; Alter M; Kahana E
Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
Modlin JF; Jabbour JT; Witte JJ; Halsey NA
Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
[TBL] [Abstract][Full Text] [Related]
7. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
Takasu T; Mgone JM; Mgone CS; Miki K; Komase K; Namae H; Saito Y; Kokubun Y; Nishimura T; Kawanishi R; Mizutani T; Markus TJ; Kono J; Asuo PG; Alpers MP
Epidemiol Infect; 2003 Oct; 131(2):887-98. PubMed ID: 14596530
[TBL] [Abstract][Full Text] [Related]
8. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
[TBL] [Abstract][Full Text] [Related]
9. Subacute sclerosing panencephalitis in Wales.
Sussman J; Compston DA
Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
[TBL] [Abstract][Full Text] [Related]
10. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
[TBL] [Abstract][Full Text] [Related]
11. Review of the effect of measles vaccination on the epidemiology of SSPE.
Campbell H; Andrews N; Brown KE; Miller E
Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
[TBL] [Abstract][Full Text] [Related]
12. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
Ibrahim SH; Amjad N; Saleem AF; Chand P; Rafique A; Humayun KN
J Trop Pediatr; 2014 Dec; 60(6):449-53. PubMed ID: 25232151
[TBL] [Abstract][Full Text] [Related]
13. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976.
Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Sato T; Isomura S; Ueda S; Kitamura I; Kaji M
Biken J; 1978 Mar; 21(A):9-14. PubMed ID: 666722
[TBL] [Abstract][Full Text] [Related]
14. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
Enders-Ruckle G
Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
[TBL] [Abstract][Full Text] [Related]
15. A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: An emergence in a time of measles.
Lam T; Ranjan R; Newark K; Surana S; Bhangu N; Lazenbury A; Childs AM; Abbey I; Gibbon F; Thomas G; Singh J; Prabhakar P; Kaminska M; Lascelles K; Hacohen Y; Brown K; Lim M
Eur J Paediatr Neurol; 2021 Sep; 34():43-49. PubMed ID: 34388650
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.
Miller C; Farrington CP; Harbert K
Int J Epidemiol; 1992 Oct; 21(5):998-1006. PubMed ID: 1468866
[TBL] [Abstract][Full Text] [Related]
17. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
[TBL] [Abstract][Full Text] [Related]
18. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
Pallivathucal LB; Noymer A
Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the correlation between measles and subacute sclerosis panencephalitis (SSPE) before and after introduction of vaccination in Poland].
Gut W; Naruszewicz-Lesiuk D
Przegl Epidemiol; 1992; 46(4):295-301. PubMed ID: 1305779
[TBL] [Abstract][Full Text] [Related]
20. Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
Manning L; Laman M; Edoni H; Mueller I; Karunajeewa HA; Smith D; Hwaiwhanje I; Siba PM; Davis TM
PLoS Negl Trop Dis; 2011 Jan; 5(1):e932. PubMed ID: 21245918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
